AtriCure, Inc. (ATRC) Stock Analysis
A live, multi-source view of AtriCure, Inc. (ATRC): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About AtriCure, Inc.
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation.
Sector: Healthcare · Industry: Medical Instruments & Supplies · United States · 1,350 employees · atricure.com
ATRC earnings date
Latest earnings: Q2 2026, published Jul 23, 2026. EPS beat. Read the summary
No earnings report for AtriCure, Inc. (ATRC) is on the Finnhub calendar through Friday, October 9, 2026.
Source: Finnhub earnings calendar, filtered to RapidTradeView’s universe; times are Eastern. Earnings today · This week
Key statistics · as of 2026-09-16
As of 2026-09-16, AtriCure, Inc. (ATRC) had a market capitalization of $2.86B, a trailing P/E of 267.7 (forward 130.2) and a beta of 1.26; the shares traded in a 52-week range of $25.36 – $56.78 (59.4% over the year).
- Market cap
- $2.86B
- Enterprise value
- $2.77B
- Trailing P/E
- 267.7
- Forward P/E
- 130.2
- PEG ratio
- 10.00
- Price / book
- 5.54
- EPS (trailing)
- $0.21
- EPS (forward)
- $0.43
- Payout ratio
- 0.0%
- 52-week range
- $25.36 – $56.78
- 52-week change
- 59.4%
- Beta
- 1.26
- Average volume
- 957,108
- Shares outstanding
- 50.9M
- Short % of float
- 8.48%
- Profit margin
- 1.9%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-22
In RapidTradeView’s 2026-09-22 scan of the US universe, AtriCure, Inc. (ATRC) last closed at $58.32 (the last completed close before that scan).
Technicals at the scan: RSI 78 (overbought territory), price +10.4% versus its 20-day average, 20-day versus 50-day average spread +17.6%, MACD histogram 0.20.
Sentiment inputs: analyst consensus score 78/100.
Next scheduled company event: in 35 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 1 buy and 0 sells of ATRC; corporate insiders filed 0 buys and 1 sell (2 distinct filers, latest disclosure 2026-09-14). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Regina E. Groves (0B/1S), Gilbert Ray Cisneros, Jr. (1B/0S). Who is trading what
RapidTradeView pick record
ATRC has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls AtriCure, Inc. (ATRC) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell ATRC.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.